These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 26081469)
1. Eliminate mitochondrial diseases by gene editing in germ-line cells and embryos. Wang S; Yi F; Qu J Protein Cell; 2015 Jul; 6(7):472-5. PubMed ID: 26081469 [TBL] [Abstract][Full Text] [Related]
2. Human germ line editing-roles and responsibilities. Lunshof JE Protein Cell; 2016 Jan; 7(1):7-10. PubMed ID: 26511643 [No Abstract] [Full Text] [Related]
6. SCIENCE AND REGULATION. The FDA is prohibited from going germline. Cohen IG; Adashi EY Science; 2016 Aug; 353(6299):545-6. PubMed ID: 27493171 [No Abstract] [Full Text] [Related]
7. Mitochondrial replacement: from basic research to assisted reproductive technology portfolio tool-technicalities and possible risks. Cree L; Loi P Mol Hum Reprod; 2015 Jan; 21(1):3-10. PubMed ID: 25425606 [TBL] [Abstract][Full Text] [Related]
8. The moral imperative to continue gene editing research on human embryos. Savulescu J; Pugh J; Douglas T; Gyngell C Protein Cell; 2015 Jul; 6(7):476-9. PubMed ID: 26113289 [No Abstract] [Full Text] [Related]
9. How bans on germline editing deprive patients with mitochondrial disease. Cohen IG; Adashi EY; Ravitsky V Nat Biotechnol; 2019 Jun; 37(6):589-592. PubMed ID: 31110356 [No Abstract] [Full Text] [Related]